BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 6
• 7
• 8
• 9
• 10
• 11
• 13
• 14
• 15
• 16
• 17
• 18
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 28
• 29
• 30
• 31

• Policy

  TissueTech, Inc. Awarded Patent for Compositions of Morselized Umbilical Cord and Amniotic Membrane

  TissueTech Inc., the pioneer in the development and clinical application of regenerative amniotic tissue-based products, announced that it has been awarded patent 9,808,491 by the U.S. Patent Trademark Office.

  May 14, 2018

   · 

  2 min read
• FDA

  BMG Pharma: GelX® Approved in Europe for Prevention of Oral Mucositis in Cancer Patients

  BMG Pharma S.r.l., an innovative specialty pharmaceutical company, is pleased to announce the European regulatory approval for its GelX product to be used for the prevention of oral mucositis.

  May 14, 2018

   · 

  2 min read
• Drug Development

  CStone announces first patient dosing with anti-PD-1 antibody CS1003 in Phase I study in Australia

  Second pipeline candidate to enter Phase I studies in Australia within one month

  May 14, 2018

   · 

  4 min read
• Business

  Bruker Announces Quarterly Dividends

  Bruker Corporation (NASDAQ: BRKR) today announced payment of a quarterly cash dividend in the amount of $0.04 per share on the Company’s common stock.

  May 14, 2018

   · 

  1 min read
• FDA

  CurveBeam Announces FDA 510(k) Clearance for LineUP Weight Bearing Multi-Extremity CT System

  Compact system enables radiologists and orthopedic specialists to visualize three-dimensional bone detail of the lower extremities while the patient is standing

  May 14, 2018

   · 

  2 min read
• Drug Development

  Alkahest Announces Initiation of Two Phase 2 Clinical Trials of ALK4290 in Age-Related Macular Degeneration

  Alkahest Inc. is a clinical-stage biotechnology company focused on developing innovative therapies to treat age-related diseases

  May 14, 2018

   · 

  3 min read
• Business

  Accomplished Global Pharmaceutical Executive, Federico Seghi Recli, Appointed To Titan’s Board

  Titan develops proprietary therapeutics for the treatment of select chronic diseases utilizing its ProNeura™ long-term, continuous drug delivery technology.

  May 14, 2018

   · 

  4 min read
• Business

  TP Therapeutics Appoints Athena Countouriotis, M.D., as EVP and Chief Medical Officer

  TP Therapeutics is a clinical-stage biopharmaceutical company developing oncology therapies with a focus on addressing current drug resistance.

  May 14, 2018

   · 

  4 min read
• Pharm Country

  SCIEX Announces New BioPharmaView Software 3.0 for Streamlining Multiple-Attribute Methods (MAM)

  Complete and easy-to-use LC-MS-based solution for biotherapeutics characterization and quality testing

  May 14, 2018

   · 

  4 min read
• Pharm Country

  GRYT Health’s Stupid Cancer App Named as Finalist in 2018 APPY Awards

  Recognized as a finalist in the non-profit category, the Stupid Cancer App provides instant, anonymous peer support and tailored information to anyone impacted by cancer.

  May 14, 2018

   · 

  3 min read